The World Health organisation (WHO) estimates that approximately 552 million adults are expected to have diabetes by 2030, and diabetes-related cognitive dysfunction is likely to be a major challenge in terms of future health resource requirements (3, 4) (Figure 1)
The healing benefits extend beyond acute injuries
In some cases, healthcare providers may adjust the frequency, for example, some patients might be advised to take the injection twice weekly or once every two weeks, depending on their specific goals and how they respond to treatment
That works, but leaves no room for error
Many are familiar with research peptides
Periodic reassessment every 6 to 12 weeks by labs and outcome measures enables clinicians to fine-tune the protocol